financetom
Business
financetom
/
Business
/
Siemens Energy to cut 7,800 jobs in face of coal phase-out
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Siemens Energy to cut 7,800 jobs in face of coal phase-out
Feb 2, 2021 6:21 AM

Siemens Energy, which supplies turbines to the power sector, will cut 7,800 jobs to counter a drop in demand for new coal-fired energy stations that has also hit rivals General Electric and Mitsubishi Heavy Industries. Siemens Energy last year announced it would no longer bid in tenders to supply turbines to coal-fired power plants, responding to a weakening market as numerous governments around the world are phasing out the polluting fuel.

The jobs to be lost represent 8.5 percent of the company’s workforce. The bulk of the cuts will be implemented by 2023 and incur restructuring costs in a mid-to high-triple-digit million euro range for the fiscal years 2020 to 2023, it said.

”The energy market is significantly changing which offers us opportunities but at the same time presents us with great challenges,” Chief Executive Christian Bruch said. ”We will undertake these measures in the most socially responsible way possible.”

In a sector shaped by fierce rivalry, General Electric filed a lawsuit last month accusing a unit of Siemens Energy of using stolen trade secrets to rig bids for gas turbine contracts.

Bruch said Siemens Energy had received the lawsuit, adding it would carefully examine the claims.

Cost cuts also helped Siemens Energy, spun off from Siemens AG last year, swing to a net profit of 99 million euros ($119.5 million) in the first quarter of its fiscal year, compared with a loss of 195 million a year ago.

The company also holds a majority stake in Siemens Gamesa, the world’s second-largest wind turbine maker after Denmark’s Vestas, which is benefiting from a global shift towards renewable energy and away from fossil fuels.

($1 = 0.8282 euros)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Keysight Develops Wire Bond Inspection Technology for Semiconductor Manufacturing
Keysight Develops Wire Bond Inspection Technology for Semiconductor Manufacturing
Aug 29, 2024
11:28 AM EDT, 08/28/2024 (MT Newswires) -- Keysight Technologies ( KEYS ) said Wednesday it has developed a new wire bond inspection technology for semiconductor manufacturing. The Electrical Structural Tester technology can identify defects like wire sag, near shorts, and stray wires for comprehensive assessment of wire bond integrity, the company said. Price: 152.91, Change: -1.19, Percent Change: -0.78 ...
Lululemon to fast-track hot new styles after 'Breezethrough' fiasco
Lululemon to fast-track hot new styles after 'Breezethrough' fiasco
Aug 29, 2024
By Savyata Mishra (Reuters) - Eager to move on from embarrassing reviews of its Breezethrough leggings that led Lululemon Athletica ( LULU ) to pull them off shelves, the pricey athleisure maker on Thursday promised to fast-track hot styles to the market. The Vancouver, Canada-based company stopped sales of the newly launched $98 leggings in July as shoppers criticized the...
Nexstar Media Group Insider Sold Shares Worth $1,061,375, According to a Recent SEC Filing
Nexstar Media Group Insider Sold Shares Worth $1,061,375, According to a Recent SEC Filing
Aug 29, 2024
11:26 AM EDT, 08/28/2024 (MT Newswires) -- Rachel Morgan, Executive Vice President and General Counsel, on August 27, 2024, sold 6,196 shares in Nexstar Media Group ( NXST ) for $1,061,375. SEC Filing: https://www.sec.gov/Archives/edgar/data/1142417/000095017024101258/xslF345X05/ownership.xml Price: 169.71, Change: +0.50, Percent Change: +0.30 ...
Akero Therapeutics Insider Sold Shares Worth $386,714, According to a Recent SEC Filing
Akero Therapeutics Insider Sold Shares Worth $386,714, According to a Recent SEC Filing
Aug 29, 2024
11:26 AM EDT, 08/28/2024 (MT Newswires) -- Catriona Yale, Chief Development Officer, on August 23, 2024, sold 14,051 shares in Akero Therapeutics ( AKRO ) for $386,714. Following the Form 4 filing with the SEC, Yale has control over a total of 75,931 shares of the company, with 75,931 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1744659/000095017024101257/xslF345X05/ownership.xml Price: 26.21, Change: -0.11, Percent...
Copyright 2023-2025 - www.financetom.com All Rights Reserved